Prognostic value of TP53 transcriptional activity on p21 and bax in patients with esophageal squamous cell carcinomas treated by definitive chemoradiotherapy.

Michel, Pierre

Prognostic value of TP53 transcriptional activity on p21 and bax in patients with esophageal squamous cell carcinomas treated by definitive chemoradiotherapy. [electronic resource] - International journal of radiation oncology, biology, physics Oct 2002 - 379-85 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0360-3016

10.1016/s0360-3016(02)02911-5 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carcinoma, Squamous Cell--drug therapy
Cisplatin--administration & dosage
Confidence Intervals
Esophageal Neoplasms--drug therapy
Female
Fluorouracil--administration & dosage
Humans
Male
Middle Aged
Mutation--physiology
Ploidies
Prognosis
Prospective Studies
Proto-Oncogene Proteins--metabolism
Proto-Oncogene Proteins c-bcl-2
Proto-Oncogene Proteins p21(ras)--metabolism
Survival Rate
Transcriptional Activation
Tumor Suppressor Protein p53--genetics
bcl-2-Associated X Protein